Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET Imaging of Noradrenergic Transmission in the Brain
NCT07686393Phase 1Recruiting
- Sponsor
- National Institute of Mental Health
- Start
- Aug 2026
- Primary completion
- Feb 2029
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 11C-ARMI, sponsored by National Institute of Mental Health. Primary endpoint: Distribution Volume (VT) at 24 months. Started Aug 2026; status: recruiting.
02
Drugs
11C-ARMI
Beyond the preview
Go deeper on NCT07686393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07686393.